Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM

How might mavacamten aid in the treatment of obstructive hypertrophic cardiomyopathy? Explore the latest findings in this session recap from ACC 2022.

ReachMD Healthcare Image
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free